India’s first NBA player Satnam Singh Bhamara has been banned for two years by the National Anti-Doping Agency’s (NADA) disciplinary panel (ADDP) for consuming prohibited specified substance, Higenamine – beta-2 agonist.
NADA said Bhamara had tested positive for Higenamine, which was added to the World Anti-Doping Agency’s (WADA) Prohibited List in 2017 and is classified as a beta-2 agonist, meaning it is prohibited at all times, both in and out-of-competition.
The 25 year-old who became the first Indian to play in the National Basketball League of Canada after signing a deal with St John’s Edge, failed an out-of-competition test conducted by NADA in Bengaluru during the preparatory camp for the South Asian Games (SAG) in November last year.
Satnam Singh Bhamara’s suspension will end on November 19 next year, with the ban period starting retrospectively on the same day in 2019.
The ban means he won’t be able to represent India or feature in any international leagues or appear in try-outs.